Royalty Pharma plc announced a dividend of $0.235 per Class A ordinary share for the third quarter of 2026. The dividend will be paid on September 10, 2026, to shareholders registered by August 14, 2026. This reflects Royalty Pharma's ongoing commitment to returning value to shareholders amid its role as a major buyer of biopharmaceutical royalties. Investors can expect the company to continue leveraging its portfolio of royalties from leading therapies to support innovation and generate returns.
Vicor Corporation is positioned for significant growth driven by rising demand for high-power-density energy conversion solutions in AI infrastructure. Its advanced technologies, including Vertical Power Delivery and Factorized Power Architecture, ca...
Alcon reported a 17% increase in core operating profit for Q2 2026, excluding a one-time $402 million non-cash charge. Revenue, adjusted for currency effects, rose 7% in the quarter. The company raised its full-year 2026 profit forecast for the secon...
Michael Egorov, founder of Curve Finance, harshly criticized Solana's Pump.fun platform, calling it a "casino of scams" due to its memecoin culture. He also pointed out that Phantom wallet's hardware wallet integration is inferior to Ethereum's Metam...
BitMart founder Sheldon Xia plans to involve law enforcement and pursue data forensics after former employees raised issues about unpaid salaries during the exchange's ongoing shutdown. BitMart announced its wind-down in July 2026, with full closure ...
HIVE Digital Technologies, through its subsidiary BUZZ High Performance Computing, signed a $350 million five-year GPU cloud services contract with an investment-grade customer. This deal adds about $70 million in annual revenue, raising BUZZ HPC's t...
